Anne B. Rossebø

3.4k total citations · 1 hit paper
45 papers, 2.3k citations indexed

About

Anne B. Rossebø is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Anne B. Rossebø has authored 45 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Cardiology and Cardiovascular Medicine, 24 papers in Radiology, Nuclear Medicine and Imaging and 12 papers in Surgery. Recurrent topics in Anne B. Rossebø's work include Cardiac Valve Diseases and Treatments (39 papers), Cardiac Imaging and Diagnostics (24 papers) and Cardiovascular Function and Risk Factors (17 papers). Anne B. Rossebø is often cited by papers focused on Cardiac Valve Diseases and Treatments (39 papers), Cardiac Imaging and Diagnostics (24 papers) and Cardiovascular Function and Risk Factors (17 papers). Anne B. Rossebø collaborates with scholars based in Norway, Germany and Denmark. Anne B. Rossebø's co-authors include Eva Gerdts, Kristian Wachtell, Kurt Boman, Terje R. Pedersen, Simon Ray, Christa Gohlke-Bärwolf, Kenneth Egstrup, Christoph Nienaber, Ronnie Willenheimer and John B. Chambers and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Anne B. Rossebø

44 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis

2008 1.1k citations Anne B. Rossebø, Terje R. Pedersen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne B. Rossebø Norway	22	1.9k	829	635	567	448	45	2.3k
Kwan L. Chan Canada	22	1.8k 1.0×	839 1.0×	411 0.6×	703 1.2×	617 1.4×	64	2.3k
Egbert T. Bal Netherlands	18	1.4k 0.8×	1.5k 1.8×	482 0.8×	176 0.3×	455 1.0×	36	2.3k
Gilles Lemesle France	30	2.0k 1.1×	1.2k 1.5×	554 0.9×	272 0.5×	321 0.7×	161	3.0k
Matthew T. Roe United States	24	1.0k 0.5×	1.3k 1.5×	323 0.5×	117 0.2×	170 0.4×	54	1.8k
Paul Guedeney France	18	1.1k 0.6×	701 0.8×	344 0.5×	233 0.4×	201 0.4×	90	1.6k
Anthony J. Dalby United States	19	2.2k 1.2×	1.1k 1.3×	256 0.4×	117 0.2×	199 0.4×	34	2.6k
Tingfei Hu United States	13	771 0.4×	826 1.0×	183 0.3×	162 0.3×	160 0.4×	17	1.4k
Laura H. Gardner United States	12	939 0.5×	1.2k 1.5×	294 0.5×	126 0.2×	92 0.2×	18	1.6k
Jean‐Paul R. Herrman Netherlands	14	2.0k 1.1×	1.2k 1.4×	382 0.6×	77 0.1×	154 0.3×	21	2.5k
Edward T.A. Fry United States	14	2.5k 1.3×	1.5k 1.8×	257 0.4×	111 0.2×	301 0.7×	40	2.8k

Countries citing papers authored by Anne B. Rossebø

Since Specialization

Citations

This map shows the geographic impact of Anne B. Rossebø's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne B. Rossebø with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne B. Rossebø more than expected).

Fields of papers citing papers by Anne B. Rossebø

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne B. Rossebø. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne B. Rossebø. The network helps show where Anne B. Rossebø may publish in the future.

Co-authorship network of co-authors of Anne B. Rossebø

This figure shows the co-authorship network connecting the top 25 collaborators of Anne B. Rossebø. A scholar is included among the top collaborators of Anne B. Rossebø based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne B. Rossebø. Anne B. Rossebø is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Greve, Anders M., Ahmad Sajadieh, Michael Hecht Olsen, et al.. (2024). Development and validation of the Aortic valve Stenosis Guarded by Amplified Risk Determination (ASGARD) risk score for safe monitoring in asymptomatic non-severe aortic valve stenosis. European Journal of Preventive Cardiology. 32(17). 1793–1803. 2 indexed citations

Larstorp, Anne Cecilie K., et al.. (2024). Gender Differences in Cardiac Organ Damage in Arterial Hypertension: Assessing the Role of Drug Nonadherence. High Blood Pressure & Cardiovascular Prevention. 31(2). 157–166. 1 indexed citations

Greve, Anders M., Ahmad Sajadieh, Michael Hecht Olsen, et al.. (2023). Association of high-sensitivity troponin T with outcomes in asymptomatic non-severe aortic stenosis: a post-hoc substudy of the SEAS trial. EClinicalMedicine. 58. 101875–101875. 3 indexed citations

Bang, Casper N., Anders M. Greve, Anne B. Rossebø, et al.. (2017). Antihypertensive Treatment With β‐Blockade in Patients With Asymptomatic Aortic Stenosis and Association With Cardiovascular Events. Journal of the American Heart Association. 6(12). 22 indexed citations

Bang, Casper N., Anders M. Greve, Lars Køber, et al.. (2014). Renin–angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis. International Journal of Cardiology. 175(3). 492–498. 33 indexed citations

Greve, Anders M., Morten Dalsgaard, Casper N. Bang, et al.. (2014). Usefulness of the Electrocardiogram in Predicting Cardiovascular Mortality in Asymptomatic Adults With Aortic Stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis Study). The American Journal of Cardiology. 114(5). 751–756. 8 indexed citations

Bang, Casper N., Morten Dalsgaard, Anders M. Greve, et al.. (2013). Left atrial size and function as predictors of new-onset of atrial fibrillation in patients with asymptomatic aortic stenosis: The simvastatin and ezetimibe in aortic stenosis study. International Journal of Cardiology. 168(3). 2322–2327. 29 indexed citations

Cioffi, Giovanni, Dana Cramariuc, Morten Dalsgaard, et al.. (2012). Left Atrial Systolic Force and Outcome in Asymptomatic Mild to Moderate Aortic Stenosis. Echocardiography. 29(9). 1038–1044. 10 indexed citations

Bang, Casper N., Anders M. Greve, Kurt Boman, et al.. (2012). Effect of lipid lowering on new-onset atrial fibrillation in patients with asymptomatic aortic stenosis: The Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study. American Heart Journal. 163(4). 690–696. 11 indexed citations

10.

Greve, Anders M., Kurt Boman, Christa Gohlke-Baerwolf, et al.. (2011). Clinical Implications of Electrocardiographic Left Ventricular Strain and Hypertrophy in Asymptomatic Patients With Aortic Stenosis. Circulation. 125(2). 346–353. 49 indexed citations

11.

Jander, Nikolaus, Jan Minners, Ingar Holme, et al.. (2011). Outcome of Patients With Low-Gradient “Severe” Aortic Stenosis and Preserved Ejection Fraction. Circulation. 123(8). 887–895. 203 indexed citations

12.

Greve, Anders M., Eva Gerdts, Kurt Boman, et al.. (2011). Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: The Simvastatin and Ezetimibe in Aortic Stenosis study. International Journal of Cardiology. 166(1). 72–76. 41 indexed citations

13.

Greve, Anders M., Eva Gerdts, Kurt Boman, et al.. (2011). Differences in Cardiovascular Risk Profile Between Electrocardiographic Hypertrophy Versus Strain in Asymptomatic Patients With Aortic Stenosis (from SEAS Data). The American Journal of Cardiology. 108(4). 541–547. 23 indexed citations

14.

Rossebø, Anne B., Christa Gohlke-Bärwolf, Kurt Boman, et al.. (2010). Risk factors for unexpected sudden death in patients with non-symptomatic aortic stenosis (the SEAS study). Lund University Publications (Lund University). 2 indexed citations

15.

Gohlke-Bärwolf, Christa, et al.. (2010). Effect of Obesity on Left Ventricular Mass and Systolic Function in Patients With Asymptomatic Aortic Stenosis (a Simvastatin Ezetimibe in Aortic Stenosis [SEAS] Substudy). The American Journal of Cardiology. 105(10). 1456–1460. 37 indexed citations

16.

Gerdts, Eva, Anne B. Rossebø, Terje R. Pedersen, et al.. (2010). Impact of Baseline Severity of Aortic Valve Stenosis on Effect of Intensive Lipid Lowering Therapy (from the SEAS Study). The American Journal of Cardiology. 106(11). 1634–1639. 22 indexed citations

17.

Holme, Ingar, Kurt Boman, Philippe Brudi, et al.. (2010). Observed and Predicted Reduction of Ischemic Cardiovascular Events in the Simvastatin and Ezetimibe in Aortic Stenosis Trial. The American Journal of Cardiology. 105(12). 1802–1808. 51 indexed citations

18.

Steine, Kjetil, Anne B. Rossebø, Marie Stugaard, & Terje R. Pedersen. (2008). Left Ventricular Systolic and Diastolic Function in Asymptomatic Patients With Moderate Aortic Stenosis. The American Journal of Cardiology. 102(7). 897–901. 36 indexed citations

19.

Cramariuc, Dana, Åshild E. Rieck, Eva M. Staal, et al.. (2007). Factors Influencing Left Ventricular Structure and Stress-Corrected Systolic Function in Men and Women With Asymptomatic Aortic Valve Stenosis (a SEAS Substudy). The American Journal of Cardiology. 101(4). 510–515. 68 indexed citations

20.

Rossebø, Anne B. & Terje R. Pedersen. (2004). Hyperlipidaemia and aortic valve disease. Current Opinion in Lipidology. 15(4). 447–451. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact